Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodiesBrian H. Santich, Nai‐Kong V. Cheung, Morgan Huse et al.|Science Translational Medicine|2020Cited by 83
Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumorsMing Cheng, Nai‐Kong V. Cheung, Brian H. Santich et al.|OncoImmunology|2016Cited by 41